Endomorphin-1 and endomorphin-2:: pharmacology of the selective endogenous μ-opioid receptor agonists

被引:95
作者
Horvath, G
机构
[1] Univ Szeged, Fac Med, Dept Physiol, H-6701 Szeged, Hungary
[2] Univ Szeged, Fac Hlth Sci, H-6701 Szeged, Hungary
关键词
antinociception; endomorphin-1; endomorphin-2; endogenous peptide; cardiovascular; mu-opioid receptor;
D O I
10.1016/S0163-7258(00)00100-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The recently discovered endogenous opioid peptides, endomorphins-1 and -2, appear to have properties consistent with neurotransmitter/neuromodulator actions in mammals. This review surveys the information gained so far from studies of different aspects of the endomorphins. Thus, the endomorphins have been found unequally in the brain; they are stored in neurons and axon terminals, with a heterogeneous distribution; they are released from synaptosomes by depolarization; they are enzymatically converted by endopeptidases; and they interact specifically and with high affinity with mu -opioid receptors. The most outstanding effect of the endomorphins is their antinociceptive action. This depends on both central and peripheral neurons. Additionally, the endomorphins cause vasodilatation by stimulating nitric oxide release from the endothelium. Their roles in different central and peripheral functions, however, have not been fully clarified yet. From a therapeutic perspective, therefore, they may be conceived at present as potent antinociceptive and vasodilator agents. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:437 / 463
页数:27
相关论文
共 107 条
[81]   Differential involvement of μ-opioid receptor subtypes in endomorphin-1-and-2-induced antinociception [J].
Sakurada, S ;
Zadina, JE ;
Kastin, AJ ;
Katsuyama, S ;
Fujimura, T ;
Murayama, K ;
Yuki, M ;
Ueda, H ;
Sakurada, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (01) :25-30
[82]   Antisense oligodeoxynucleotides targeting distinct exons of the cloned mu-opioid receptor distinguish between endomorphin-1 and morphine supraspinal antinociception in mice [J].
Sánchez-Blázquez, P ;
DeAntonio, I ;
Rodríguez-Díaz, M ;
Garzón, J .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (03) :253-260
[83]  
Sánchez-Blázquez P, 1999, J PHARMACOL EXP THER, V291, P12
[84]  
Sbrenna S, 1999, J PHARMACOL EXP THER, V291, P1365
[85]   Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord [J].
Schreff, M ;
Schulz, S ;
Wiborny, D ;
Höllt, V .
NEUROREPORT, 1998, 9 (06) :1031-1034
[86]   Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV [J].
Shane, R ;
Wilk, S ;
Bodnar, RJ .
BRAIN RESEARCH, 1999, 815 (02) :278-286
[87]  
Sim LJ, 1998, J NEUROCHEM, V70, P1567
[88]   In vitro binding and signaling profile of the novel μ opioid receptor agonist endomorphin 2 in rat brain membranes [J].
Spetea, M ;
Monory, K ;
Tömböly, C ;
Tóth, G ;
Tzavara, E ;
Benyhe, S ;
Hanoune, J ;
Borsodi, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (03) :720-725
[89]   Expression of δ, κ and μ human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins [J].
Stanasila, L ;
Massotte, D ;
Kieffer, BL ;
Pattus, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 260 (02) :430-438
[90]  
Stefanis CN, 1999, WPA SER EVID EXPER P, V1, P1